Wang, J.; Zhao, Y.; Xie, S.; Liu, H.; Di, M.; Wang, B.; Tang, B.; Xie, W.; Yang, X.; Lai, Z.;
et al. Development and Preliminary Validation of a MALDI-TOF MS Assay Using KTI as an Internal Standard for Serum M-Protein Light Chain Analysis in Multiple Myeloma: A Pilot Study. Medicina 2026, 62, 1057.
https://doi.org/10.3390/medicina62061057
AMA Style
Wang J, Zhao Y, Xie S, Liu H, Di M, Wang B, Tang B, Xie W, Yang X, Lai Z,
et al. Development and Preliminary Validation of a MALDI-TOF MS Assay Using KTI as an Internal Standard for Serum M-Protein Light Chain Analysis in Multiple Myeloma: A Pilot Study. Medicina. 2026; 62(6):1057.
https://doi.org/10.3390/medicina62061057
Chicago/Turabian Style
Wang, Jin, Yiming Zhao, Shuanglian Xie, Huihui Liu, Mingyi Di, Bingjie Wang, Bo Tang, Weiwei Xie, Xiaoying Yang, Zhizhen Lai,
and et al. 2026. "Development and Preliminary Validation of a MALDI-TOF MS Assay Using KTI as an Internal Standard for Serum M-Protein Light Chain Analysis in Multiple Myeloma: A Pilot Study" Medicina 62, no. 6: 1057.
https://doi.org/10.3390/medicina62061057
APA Style
Wang, J., Zhao, Y., Xie, S., Liu, H., Di, M., Wang, B., Tang, B., Xie, W., Yang, X., Lai, Z., & Dong, Y.
(2026). Development and Preliminary Validation of a MALDI-TOF MS Assay Using KTI as an Internal Standard for Serum M-Protein Light Chain Analysis in Multiple Myeloma: A Pilot Study. Medicina, 62(6), 1057.
https://doi.org/10.3390/medicina62061057
